BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6739896)

  • 1. [Autoimmune response in the serum of patients with cerebral gliomas].
    González C; Fumanal FJ; Roda JE
    Rev Clin Esp; 1984 Apr; 173(1):45-7. PubMed ID: 6739896
    [No Abstract]   [Full Text] [Related]  

  • 2. [Studies on cellular immunity of brain tumors; glial carcinofetal antigens and serum blocking factors in gliomas (author's transl)].
    Oda Y
    Nihon Geka Hokan; 1974 Mar; 43(2):111-23. PubMed ID: 4472615
    [No Abstract]   [Full Text] [Related]  

  • 3. Monoclonal antibody ONS-M21 recognizes integrin alpha3 in gliomas and medulloblastomas.
    Kishima H; Shimizu K; Tamura K; Miyao Y; Mabuchi E; Tominaga E; Matsuzaki J; Hayakawa T
    Br J Cancer; 1999 Jan; 79(2):333-9. PubMed ID: 9888477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lymphocytic infiltration in gliomas: evidence of possible host resistance.
    Ridley A; Cavanagh JB
    Brain; 1971; 94(1):117-24. PubMed ID: 5552158
    [No Abstract]   [Full Text] [Related]  

  • 5. [Detection of tumors specific humoral anitbody against brain tumors (author'stransl)].
    Shimizu T; Kito K; Kubota S; Kitamura K; Takakura K
    No Shinkei Geka; 1974; 2(11-12):747-56. PubMed ID: 4376831
    [No Abstract]   [Full Text] [Related]  

  • 6. [Active immunotherapy of cerebral tumor. 20 cases].
    Trouillas P; Lapras C
    Neurochirurgie; 1970; 16(2):143-70. PubMed ID: 4317954
    [No Abstract]   [Full Text] [Related]  

  • 7. Human monoclonal antibodies to glioma cells.
    Sikora K; Phillips J
    Br J Cancer; 1981 Jan; 43(1):105-7. PubMed ID: 6970048
    [No Abstract]   [Full Text] [Related]  

  • 8. [Detection and clinical significance of immune complexes in the sera of brain tumor patients].
    Suda K; Ohtsuka S; Takeuchi J; Yamashita J; Oda Y; Handa H
    No Shinkei Geka; 1982 Dec; 10(12):1283-8. PubMed ID: 6302540
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Monoclonal antibodies against human brain tumors].
    Yoshida J
    Gan To Kagaku Ryoho; 1983 Jul; 10(7):1706-14. PubMed ID: 6347088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surface antigens of human glioma cells shared with normal adult and fetal brain.
    Wikstrand CJ; Bigner DD
    Cancer Res; 1979 Aug; 39(8):3235-43. PubMed ID: 88260
    [No Abstract]   [Full Text] [Related]  

  • 11. The humoral immune response of patients to their gliomas.
    Coakham HB; Kornblith PL
    Acta Neurochir Suppl (Wien); 1979; 28(2):475-9. PubMed ID: 290238
    [No Abstract]   [Full Text] [Related]  

  • 12. Challenges in the development of a survivin vaccine (SurVaxM) for malignant glioma.
    Fenstermaker RA; Ciesielski MJ
    Expert Rev Vaccines; 2014 Mar; 13(3):377-85. PubMed ID: 24521310
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serological analysis of tumor antigens in malignant glioma patients.
    Yoshida S; Tanaka R; Ono K
    Neurol Med Chir (Tokyo); 1991 Sep; 31(9):559-62. PubMed ID: 1723168
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Absence of p53 autoantibodies in sera from glioma patients.
    Rainov NG; Dobberstein KU; Fittkau M; Bahn H; Holzhausen HJ; Gantchev L; Burkert W
    Clin Cancer Res; 1995 Jul; 1(7):775-81. PubMed ID: 9816045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterisation of a new mouse monoclonal antibody (ONS-M21) reactive with both medulloblastomas and gliomas.
    Moriuchi S; Shimizu K; Miyao Y; Hayakawa T
    Br J Cancer; 1993 Nov; 68(5):831-7. PubMed ID: 8217597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanisms of local immunoresistance in glioma.
    Albesiano E; Han JE; Lim M
    Neurosurg Clin N Am; 2010 Jan; 21(1):17-29. PubMed ID: 19944963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunologic sensitization to tumor-associated antigens during the growth of gliomas of the brain (experimental study)].
    Novichenko NL; Romodanov AP; Zhmareva EN; Gorovoĭ AI
    Zh Vopr Neirokhir Im N N Burdenko; 1984; (2):9-13. PubMed ID: 6741378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Specific lymphocytotoxicity and blocking factors in tumours of the central nervous system.
    Kumar S; Taylor G
    Br J Cancer Suppl; 1973 Aug; 1():135-41. PubMed ID: 4804276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Immunofluorescence microscopy of a malignant glioma with regard to the occurrence and significance of glioma specific antibodies].
    Hackenberg P; Koschnike P
    Psychiatr Neurol Med Psychol (Leipz); 1980 Apr; 32(4):206-13. PubMed ID: 7413856
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A common repertoire of autoantibodies is shared by cancer and autoimmune disease patients: Inflammation in their induction and impact on tumor growth.
    Bei R; Masuelli L; Palumbo C; Modesti M; Modesti A
    Cancer Lett; 2009 Aug; 281(1):8-23. PubMed ID: 19091462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.